{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:33:44Z","timestamp":1740105224951,"version":"3.37.3"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004313","name":"General Electric","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12350-020-02168-3","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:02:56Z","timestamp":1588960976000},"page":"2684-2686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heart rate response to vasodilator stress: A potential new application for a proven prognostic parameter"],"prefix":"10.1016","volume":"28","author":[{"given":"Christopher L.","family":"Schumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamieson M.","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-020-02168-3_bib1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jama.281.6.524","article-title":"Impaired chronotropic response to exercise stress testing as a predictor of mortality","volume":"281","author":"Lauer","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1007\/s12350-020-02168-3_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0002-9149(99)80347-6","article-title":"Chronotropic response to exercise predicts angiographic severity in patients with suspected or stable coronary artery disease","volume":"76","author":"Brener","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-020-02168-3_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0735-1097(03)00832-5","article-title":"Prognostic significance of impairment of heart rate response to exercise: Impact of left ventricular function and myocardial ischemia","volume":"42","author":"Elhendy","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02168-3_bib4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.amjcard.2005.01.042","article-title":"Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms","volume":"95","author":"Bhatheja","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-020-02168-3_bib5","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/01.CIR.0000072770.27332.75","article-title":"Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study","volume":"107","author":"Abidov","year":"2003","journal-title":"Circulation"},{"key":"10.1007\/s12350-020-02168-3_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.105.095323","article-title":"Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats","volume":"316","author":"Dhalla","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s12350-020-02168-3_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s12149-012-0618-z","article-title":"Reduced heart rate response to dipyridamole in patients undergoing myocardial perfusion SPECT","volume":"26","author":"Gorur","year":"2012","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-020-02168-3_bib8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.semnuclmed.2011.04.001","article-title":"Cardiac applications of 123I-mIBG imaging","volume":"41","author":"Chirumamilla","year":"2011","journal-title":"Semin. Nucl. Med."},{"key":"10.1007\/s12350-020-02168-3_bib9","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02168-3_bib10","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s00259-016-3519-x","article-title":"The future of cardiac 123-I MIBG imaging","volume":"43","author":"Scholte","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1007\/s12350-020-02168-3_bib11","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s12350-018-1394-5","article-title":"How do we establish cardiac sympathetic nervous system imaging with 123I-mIBG in clinical practice? Perspectives and lessons from Japan and the US","volume":"26","author":"Travin","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02168-3_bib12","doi-asserted-by":"crossref","unstructured":"Gerson MC, Craft LL, Mcguire N, et al (2002) Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine. https:\/\/doi.org\/10.1067\/mnc.2002.127717","DOI":"10.1067\/mnc.2002.127717"},{"key":"10.1007\/s12350-020-02168-3_bib13","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s00259-004-1557-2","article-title":"Usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy for predicting the effectiveness of \u03b2-blockers in patients with dilated cardiomyopathy from the standpoint of long-term prognosis","volume":"31","author":"Fujimoto","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-020-02168-3_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jacc.2004.11.038","article-title":"Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction","volume":"45","author":"Kasama","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02168-3_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/hrt.76.3.218","article-title":"Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure","volume":"76","author":"Somsen","year":"1996","journal-title":"Heart"},{"key":"10.1007\/s12350-020-02168-3_bib16","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jacc.2007.04.095","article-title":"Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: Lessons from the MUSTT study","volume":"50","author":"Buxton","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02168-3_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1067\/mnc.2003.2","article-title":"I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defribillator","volume":"10","author":"Arora","year":"2003","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02168-3_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2967\/jnumed.107.042564","article-title":"Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function","volume":"49","author":"Nagahara","year":"2008","journal-title":"J Nucl Med"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-020-02168-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123016835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123016835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T15:51:45Z","timestamp":1735573905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123016835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1071358123016835"],"URL":"https:\/\/doi.org\/10.1007\/s12350-020-02168-3","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart rate response to vasodilator stress: A potential new application for a proven prognostic parameter","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-020-02168-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}